Completed NA INTERVENTIONAL 2-arm NCT06214910

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa (ThiPhiSA)

Sponsor: Human Sciences Research Council

Interventions Clinic-link TPT Community-delivered TB preventive therapy (TPT) - 3 months weekly isoniazid plus rifapentine (3HP)

Updated 9 times since 2024 Last updated: Dec 30, 2025 Started: Feb 20, 2024 Primary completion: May 30, 2025 Completion: Aug 4, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06214910, this NA trial focuses on HIV I Infection and Tuberculosis and remains completed. Sponsored by Human Sciences Research Council, it has been updated 9 times since 2024, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Aug 2025 — Feb 2026 [monthly]

Active Not Recruiting NA
Jun 2025 — Aug 2025 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Apr 2025 — Jun 2025 [monthly]

Recruiting NA
Sep 2024 — Apr 2025 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Aug 2024 — Sep 2024 [monthly]

Recruiting NA

Phase: PHASE4 → NA
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE4
Mar 2024 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Feb 2024 — Mar 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Human Sciences Research Council
National Institute of Allergy and Infectious Diseases (NIAID)
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sweetwaters, South Africa